Impurity testing


Author Title Reference Y V
Heo, JH et al. A microfluidic approach to high throughput quantification of host cell protein impurities for bioprocess development Pharmaceutical Bioprocessing Vol. 2, No. 2, Pages 129-139. 2014 Read
Peiris, KJ et al Development of residual host cell protein assays for recombinant microbial biopharmaceuticals 5th Annual European Gyrolab Seminar, Siena, Italy 2011 PDF
Eibl, R et al The Manufacture of mAbs – A Comparison of Performance and Process Time between Traditional and Ready-to-Use Disposable Systems Single-Use Technology in Biopharmaceutical Manufacture, Published Online: 19 Jan 2011 DOI: 10.1002/9780470909997.ch28 2011
Colombo, L et al New analytical technologies: Pharmaceutical applications to proteins and antibodies. An industry perspective National meeting on medicinal chemistry (NMMC), Abano Terme, Italy, Book of abstracts, p39-40, October 2010 2010
Mora, J et al Application of the Gyrolab platform to ligand-binding assays: a user's perspective Bioanalysis 2010, 2 (10) 1711-1715 2010 PMID
Lehtonen, P & Inganas, M Quantification of MabSelect SuRe ligand in presence of excess amounts of IgG on Gyrolab 2009 PDF
Wallby, E et al Gyrolab applications in industrial monoclonal antibody development 2009 PDF
Bishop, E Use of Gyrolab in Biotechnology Process Development Gyrolab Seminar 2008 PDF
Lehtonen, P et al Improved analytical tools for quantification of monoclonal IgG and host cell proteins during biopharmaceutical process development WCBP 2007 PDF
Österlund, K et al Automated protein quantification in bioprocess development and pharmacokinetic studies: Improving assay performance Merck Technology Symposium 2007 PDF
Inganäs, M Application report 206: Single-system solution for quantification of monoclonal IgG and host cell proteins (HCP) Gyros Application Report Product Information

You can view further information on selected references through the link in the column ‘View’ on the far right.

PDF: Download the document as a PDF file